Skip to main content

Table 2 Laboratory Findings of Alpha and Omicron Waves

From: Comparing the demographics and laboratory biomarkers of the COVID-19 Omicron wave and the Alpha wave in a predominantly Afro-Caribbean patient population in New York City

Factors

All Patients by Wave (n = 298)

All Non-Survivors by Wave (n = 197)

Omicron Wave by Survival Status (n = 27)

 

Alpha (n = 271)

 

Omicron (n = 27)

p- value

 

Alpha (n = 182)

 

Omicron (n = 15)

p- value

 

Survivor (n = 12)

 

Non-Survivor (n = 15)

p- value

n

Mean (sd.)

n

Mean (sd.)

 

n

Mean (sd.)

n

Mean (sd.)

 

n

Mean (sd.)

n

Mean (sd.)

 

Na

270

138.6 \(\pm\) 10.0

26

140.7 \(\pm\) 6.43

0.14

182

139.4 ± 9.80

15

142.3 ± 7.44

0.17

11

138.5 \(\pm\) 4.08

15

142.3 \(\pm\) 7.44

0.14

HCO3−

268

21.0 \(\pm\) 6.38

26

21.5 \(\pm\) 4.79

0.64

180

20.6 ± 5.95

15

19.4 ± 4.84

0.39

11

24.4 \(\pm\) 3.01

15

19.4 \(\pm\) 4.84

0.006

BUN

270

44.0 \(\pm\) 41.2

26

54.0 \(\pm\) 36.4

0.20

182

47.9 ± 45.1

15

58.5 ± 29.1

0.21

11

47.9 \(\pm\) 45.3

15

58.5 \(\pm\) 29.1

0.48

Cr

270

2.76 \(\pm\) 3.14

26

3.20 \(\pm\) 2.79

0.45

182

2.91 ± 3.27

15

3.26 ± 2.41

0.60

11

3.10 \(\pm\) 3.36

15

3.26 \(\pm\) 2.41

0.88

AST

249

120.0 \(\pm\) 340.4

25

100.4 \(\pm\) 161.0

0.62

164

139.4 ± 404.1

14

100.9 ± 166.1

0.48

11

99.7 \(\pm\) 162.2

14

100.9 \(\pm\) 166.1

0.99

ALT

249

67.4 \(\pm\) 137.4

25

40.2 \(\pm\) 44.4

0.03

164

74.4 ± 160.5

14

46.5 ± 43.1

0.11

11

32.3 \(\pm\) 46.8

14

46.5 \(\pm\) 43.1

0.44

Total Bilirubin

250

0.840 \(\pm\) 1.08

25

1.22 \(\pm\) 2.83

0.51

165

0.866 ± 1.15

14

1.54 ± 3.77

0.52

11

0.827 \(\pm\) 0.706

14

1.54 \(\pm\) 3.77

0.55

Neu %

221

82.6 \(\pm\) 8.42

25

77.6 \(\pm\) 13.7

0.09

151

83.9 ± 7.48

13

79.7 ± 13.6

0.29

12

75.3 \(\pm\) 14.1

13

79.7 \(\pm\) 13.6

0.44

Lym %

227

9.94 \(\pm\) 6.69

24

13.8 \(\pm\) 11.8

0.13

154

9.06 ± 5.62

13

12.2 ± 12.4

0.38

11

15.7 \(\pm\) 11.4

13

12.2 \(\pm\) 12.4

0.48

Mono %

227

4.40 \(\pm\) 2.23

24

6.41 \(\pm\) 3.11

0.005

154

4.35 ± 2.24

13

5.98 ± 3.36

0.11

11

6.91 \(\pm\) 2.85

13

5.98 \(\pm\) 3.36

0.48

Eos %

214

0.526 \(\pm\) 0.892

24

0.483 \(\pm\) 0.925

0.83

147

0.412 ± 0.572

13

0.162 ± 0.236

0.005

11

0.864 \(\pm\) 1.27

13

0.162 \(\pm\) 0.236

0.06

Baso %

210

0.418 \(\pm\) 0.327

24

0.450 \(\pm\) 0.582

0.79

144

0.406 ± 0.307

13

0.469 ± 0.641

0.73

11

0.427 \(\pm\) 0.535

13

0.469 \(\pm\) 0.641

0.86

PLT

263

249.0 \(\pm\) 123.7

26

220.4 \(\pm\) 93.7

0.16

178

228.4 ± 111.7

14

237.7 ± 116.8

0.78

12

200.3 \(\pm\) 54.8

14

237.7 \(\pm\) 116.8

0.32

WBC

264

11.7 \(\pm\) 5.70

26

10.1 \(\pm\) 7.19

0.28

179

11.7 ± 5.70

14

10.7 ± 8.25

0.66

12

9.26 \(\pm\) 5.96

14

10.7 \(\pm\) 8.25

0.61

Hemoglobin

264

12.2 \(\pm\) 2.43

26

11.4 \(\pm\) 2.51

0.14

179

12.3 ± 2.43

14

11.7 ± 2.75

0.42

12

11.1 \(\pm\) 2.27

14

11.7 \(\pm\) 2.75

0.53

  1. *Columns may not sum to 100 due to rounding
Back to article page

Pneumonia

ISSN: 2200-6133

Contact us